Stage IVB Lung Cancer AJCC v8 Recruiting Phase 2 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0111251 (Stage IVB Lung Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03662074Second Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung CancerTreatment